8-K - Nektar Therapeutics | StockGist

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

Results of Operations and Financial Condition. On November 6, 2025, Nektar Therapeutics, a Delaware corporation (“Nektar”), issued a press release (the “Press R

Financial Results

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release titled “Nektar Therapeutics Reports Third Quarter 2025 Financial Res

Exhibits Only

Source Document

Exhibits (2)

8-K

CURRENT REPORT

99.1

PRESS RELEASE TITLED "NEKTAR THERAPEUTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS."